Elan Announces Restructuring of Tysabri Collaboration with Biogen Idec

Migrate From The Current 50:50 Business Collaboration To A New Structure Upfront Payment Of $3.25 Billion Plus Double Digit Tiered Royalty For Complete Asset Tax Efficient Transaction Simplified Structure Enables Improved Alignment Of Therapy To...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news